A detailed history of Walleye Capital LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Walleye Capital LLC holds 1,700 shares of PRCT stock, worth $102,085. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,700
Previous 1,400 21.43%
Holding current value
$102,085
Previous $112,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$67.27 - $99.45 $124,987 - $184,778
1,858 Added 11.45%
18,079 $1.46 Million
Q3 2024

Nov 14, 2024

SELL
$56.31 - $84.99 $1.64 Million - $2.47 Million
-29,114 Reduced 64.22%
16,221 $1.3 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $2.07 Million - $3.14 Million
45,335 New
45,335 $2.77 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $189,661 - $330,784
7,620 New
7,620 $319,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.68B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.